MAGED4B is a Poor Prognostic Marker of Stomach Adenocarcinoma and a Potential Therapeutic Target for Stomach Adenocarcinoma Tumorigenesis

References

• Tan P, Yeoh KG. Genetics and molecular pathogenesis of gastric adenocarcinoma. Gastroenterology. 2015;149(5):1153–1162 e1153.
   PubMed Web of Science ®Google Scholar
• Zhang M, Hu S, Min M, et al. Dissecting transcriptional heterogeneity in primary gastric adenocarcinoma by single cell RNA sequencing. Gut. 2021;70(3):464–475. doi:10.1136/gutjnl-2019-320368
   PubMed Web of Science ®Google Scholar
• Lochhead P, El-Omar EM. Gastric cancer. Br Med Bull. 2008;85:87–100. doi:10.1093/bmb/ldn007
   PubMed Web of Science ®Google Scholar
• Maruyama K, Kaminishi M; Japanese Gastric Cancer Association Registration C. Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry. Gastric Cancer. 2006;9(2):51–66. doi:10.1007/s10120-006-0370-y
   PubMedGoogle Scholar
• Hundahl SA, Menck HR, Mansour EG, Winchester DP. The national cancer data base report on gastric carcinoma. Cancer. 1997;80(12):2333–2341. doi:10.1002/(SICI)1097-0142(19971215)80:12<2333::AID-CNCR15>3.0.CO;2-V
   PubMed Web of Science ®Google Scholar
• Serlin O, Keehn RJ, Higgins GA Jr, Harrower HW, Mendeloff GL. Factors related to survival following resection for gastric carcinoma: analysis of 903 cases. Cancer. 1977;40(3):1318–1329. doi:10.1002/1097-0142(197709)40:3<1318::AID-CNCR2820400349>3.0.CO;2-9
   PubMed Web of Science ®Google Scholar
• Adachi Y, Yasuda K, Inomata M, Sato K, Shiraishi N, Kitano S. Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type. Cancer. 2000;89(7):1418–1424. doi:10.1002/1097-0142(20001001)89:7<1418::AID-CNCR2>3.0.CO;2-A
   PubMed Web of Science ®Google Scholar
• Siewert JR, Bottcher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric cancer: ten-year results of the German gastric cancer study. Ann Surg. 1998;228(4):449–461. doi:10.1097/00000658-199810000-00002
   PubMed Web of Science ®Google Scholar
• Barker PA, Salehi A. The MAGE proteins: emerging roles in cell cycle progression, apoptosis, and neurogenetic disease. J Neurosci Res. 2002;67(6):705–712. doi:10.1002/jnr.10160
   PubMed Web of Science ®Google Scholar
• De Plaen E, Arden K, Traversari C, et al. Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics. 1994;40(5):360–369. doi:10.1007/BF01246677
   PubMed Web of Science ®Google Scholar
• Jungbluth AA, Stockert E, Chen YT, et al. Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours. Br J Cancer. 2000;83(4):493–497. doi:10.1054/bjoc.2000.1291
   PubMed Web of Science ®Google Scholar
• van der Bruggen P, Traversari C, Chomez P, et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science. 1991;254(5038):1643–1647. doi:10.1126/science.1840703
   PubMed Web of Science ®Google Scholar
• Chong CE, Lim KP, Gan CP, et al. Over-expression of MAGED4B increases cell migration and growth in oral squamous cell carcinoma and is associated with poor disease outcome. Cancer Lett. 2012;321(1):18–26. doi:10.1016/j.canlet.2012.03.025
   PubMed Web of Science ®Google Scholar
• Yang P, Huo Z, Liao H, Zhou Q. Cancer/testis antigens trigger epithelial-mesenchymal transition and genesis of cancer stem-like cells. Curr Pharm Des. 2015;21(10):1292–1300. doi:10.2174/1381612821666141211154707
   PubMed Web of Science ®Google Scholar
• Zhu W, Li H, Yu Y, et al. Enolase-1 serves as a biomarker of diagnosis and prognosis in hepatocellular carcinoma patients. Cancer Manag Res. 2018;10:5735–5745. doi:10.2147/CMAR.S182183
   PubMed Web of Science ®Google Scholar
• Justus CR, Leffler N, Ruiz-Echevarria M, Yang LV. In vitro cell migration and invasion assays. J Vis Exp. 2014;88:e51046.
   Google Scholar
• Liu C, Liu J, Shao J, et al. MAGED4B promotes glioma progression via inactivation of the tnf-alpha-induced apoptotic pathway by down-regulating TRIM27 expression. Neurosci Bull. 2022;39:273–291.
   PubMed Web of Science ®Google Scholar
• Zaman MM, Nomura T, Takagi T, et al. Ubiquitination-deubiquitination by the TRIM27-USP7 complex regulates tumor necrosis factor alpha-induced apoptosis. Mol Cell Biol. 2013;33(24):4971–4984. doi:10.1128/MCB.00465-13
   PubMed Web of Science ®Google Scholar
• Sasaki M, Nakahira K, Kawano Y, et al. MAGE-E1, a new member of the melanoma-associated antigen gene family and its expression in human glioma. Cancer Res. 2001;61(12):4809–4814.
   PubMed Web of Science ®Google Scholar
• Tsai JR, Chong IW, Chen YH, et al. Differential expression profile of MAGE family in non-small-cell lung cancer. Lung Cancer. 2007;56(2):185–192. doi:10.1016/j.lungcan.2006.12.004
   PubMed Web of Science ®Google Scholar
• Cheong SC, Chandramouli GV, Saleh A, et al. Gene expression in human oral squamous cell carcinoma is influenced by risk factor exposure. Oral Oncol. 2009;45(8):712–719. doi:10.1016/j.oraloncology.2008.11.002
   PubMed Web of Science ®Google Scholar
• Oya H, Kanda M, Takami H, et al. Overexpression of melanoma-associated antigen D4 is an independent prognostic factor in squamous cell carcinoma of the esophagus. Dis Esophagus. 2015;28(2):188–195. doi:10.1111/dote.12156
   PubMed Web of Science ®Google Scholar
• Fonseca-Sanchez MA, Perez-Plasencia C, Fernandez-Retana J, et al. microRNA-18b is upregulated in breast cancer and modulates genes involved in cell migration. Oncol Rep. 2013;30(5):2399–2410. doi:10.3892/or.2013.2691
   PubMed Web of Science ®Google Scholar
• Clynes M, O’Connor R, O’Driscoll L, Daly C, Meleady P. Challenges in molecular analysis for individualized cancer therapy. Drug Discov Today. 2003;8(12):531. doi:10.1016/S1359-6446(03)02730-2
   PubMed Web of Science ®Google Scholar
• Germano S, Kennedy S, Rani S, et al. MAGE-D4B is a novel marker of poor prognosis and potential therapeutic target involved in breast cancer tumorigenesis. Int J Cancer. 2012;130(9):1991–2002. doi:10.1002/ijc.26200
   PubMed Web of Science ®Google Scholar
• Baranwal S, Alahari SK. Molecular mechanisms controlling E-cadherin expression in breast cancer. Biochem Biophys Res Commun. 2009;384(1):6–11. doi:10.1016/j.bbrc.2009.04.051
   PubMed Web of Science ®Google Scholar
• Berx G, Van Roy F. The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res. 2001;3(5):289–293. doi:10.1186/bcr309
   PubMed Web of Science ®Google Scholar
• Chen G, Goeddel DV. TNF-R1 signaling: a beautiful pathway. Science. 2002;296(5573):1634–1635. doi:10.1126/science.1071924
   PubMed Web of Science ®Google Scholar
• Vucic D, Dixit VM, Wertz IE. Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death. Nat Rev Mol Cell Biol. 2011;12(7):439–452. doi:10.1038/nrm3143
   PubMed Web of Science ®Google Scholar